RNA interference (RNAi) is triggered by the presence of a double-stranded RNA (dsRNA) in the cell, and results in the silencing of homologous gene expression by the specific degradation of an mRNA containing the same sequence. dsRNA-mediated RNAi can be used in a wide variety of eucaryotes to induce the sequence-specific inhibition of gene expression. Synthetic 21-23 nucleotide (nt) small interfering RNAs (siRNAs) with 2-nt 3 0 overhangs were recently found to mediate efficient sequence-specific mRNA degradation in mammalian cells. Here, we show that synthetic siRNAs targeted against the viral structural Env proteins encoded by HIV-1 can specifically suppress the expression of HIV-1 genes. The siRNA-mediated RNAi also had advantages over antisense RNA-mediated inhibition, in terms of both the ease of designing effective antiviral agents and their potency. Especially, our best env-specific siRNAs, E7145 targeted to the central region of the V3 loop and E7490 targeted to the CD4 binding site of conserved regions on gp120, significantly inhibited the HIV-1 gene expression. Furthermore, E7145 and E7490 were effective against HIV-1 NL4-3 replication in PBMCs for a relatively long time (14 days). Therefore, the use of synthetic siRNAs provides a simple, rapid, and costeffective tool for new anti-HIV-1 gene therapeutics. Gene Therapy (2003) Keywords: RNA interference; small interfering RNAs; HIV-1 env genes; antiviral RNAi technology; PBMCs RNA interference (RNAi) or RNA silencing is an evolutionarily conserved phenomenon in which double-stranded RNA (dsRNA) induces the homologydependent degradation of the cognate mRNA. 1 RNAi is initiated by the RNase III-like nuclease Dicer, which promotes the processive cleavage of long dsRNAs into 21-to 23-nucleotide (nt) small interfering RNAs (siRNAs) with 2-nt 3 0 overhangs. [2][3][4][5][6] Subsequently, the siRNAs are incorporated into an RNA-induced silencing complex (RISC), identified in Drosophila, and the protein-RNA effector nuclease complex recognizes and destroys the target mRNAs. [7][8][9] It was recently found that the transfection of synthetic 21-23 nt siRNAs with 2-nt 3 0 overhangs into mammalian cells effectively inhibits the expression of the endogenous genes in a sequence-specific manner. 10-12 These small RNA duplexes, which are chemically synthesized mimics of Dicer products, are presumably incorporated into RISC and target their cognate substrates for degradation. Lee et al 13 have reported the inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the expression of small interfering RNAs targeted against HIV-1 rev in human cells. In addition, Jacque et al 14 demonstrated the utility of siRNA-mediated RNAi for modulating HIV replication by synthetic siRNAs or plasmid-derived siRNAs targeted to various regions of the HIV-1 genome (TAR, vif, nef).We previously reported that long dsRNAs effectively inhibit HIV-1 replication in HIV-1 infected cells. 15 However, the utility of these long dsRNAs appeared to be limited, due to the nonspecific inhibi...